| |
|
| |
|
| The nanomednet advisory board consists of: |
Prof. S Homer-Vanniasinkam IBSc MD FRCSED FRCS (Chair)
Consultant Vascular Surgeon, Leeds General Infirmary Professor of Translational Vascular Medicine, University of Bradford Clinical Sub-Dean, Leeds Medical School UK
http://www.leedsteachinghospitals.com/
|
Dr. Leonard Fass
Director of Academic Relations, GE Healthcare
http://www.gehealthcare.com
|
Robert Geertsma
Senior Scientist, Centre for Biological Medicines and Medical Technology, National Institute for Public Health and the Environment (RIVM)
http://www.rivm.nl/en/
|
Professor Terry Gourlay
Professor of Medical Diagnostics,
Bioengineering Unit,
Strathclyde University
http://www.strath.ac.uk/bioeng/
|
Prof. Michael Horton
Director, Bone and Mineral Centre and Sackler Institute for Musculoskeletal Research, Executive Council member of LCN, London
http://www.london-nano.ucl.ac.uk/lcn/index2.htm
|
Prof. Kostas Kostarelos
Chair in Nanomedicine,
Deputy Head, Centre for Drug Delivery Research,University of London
http://cddr.pharmacy.ac.uk/main3.html
|
Prof. Vivian Nathenson
Director of Professional Activities, British Medical Association
http://www.bma.org.uk/ap.nsf/content/splashpage
|
|
Dr. Raj Prasad
Consultant transplant and Hepatobiliary Surgeon, St James's Hospital, Leeds
http://www.leedsteachinghospitals.com/
|
Dr. Frances Rawle
Board Programme Manager, Medical Research Council, UK
http://www.mrc.ac.uk/
|
Prof. William H Stimson
Department of Immunology, Strathclyde University, Glasgow
http://www.strath.ac.uk/sipbs/
|
Dr. Ian Starke
Director, CPD, Royal College of Physicians of London
http://www.rcplondon.ac.uk/
|
Prof. Dr. Ing. Joerg Vienken
Vice President BioSciences
Fresenius Medical Care
http://www.fmc-ag.com/
|
|
|
